跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aprezin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aprezin
Approved
STANDARD
Aprezin
Pharmasant Laboratories Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
28d5939137e83c38
Company
Pharmasant Laboratories Co., Ltd.
Type
Standard
Approval Details
Approval Id
28d5939137e83c38
Drug Approval Philippines Name
Aprezin
Product Name
Aprezin
Registration Number
DR-XY36017
Brand Name
Aprezin
Generic Name
Hydralazine Hydrochloride
Dosage Form
Film Coated Tablet
Dosage Strength
25mg
Manufacturer
Pharmasant Laboratories Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 February 2022
Expiry Date
23 June 2027
Pharmacologic Category
Antihypertensive
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
28d5939137e83c38
Type
Standard
Back to Philippines FDA Approvals